Dundee University start RESCU trial of PneumoWave’s wearable biosensor device aiming to cut opioid overdose deaths
Glasgow, February 28, 2022, Healthtech company PneumoWave today announced that Dundee University is commencing the clinical trial of its wearable device that aims to reduce the growing number of fatal opioid overdoses in Scotland.